you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

BSE Live

Jul 29, 09:18
1022.10 6.50 (0.64%)
Volume
AVERAGE VOLUME
5-Day
13,220
10-Day
17,686
30-Day
30,583
117
  • Prev. Close

    1015.60

  • Open Price

    1015.60

  • Bid Price (Qty.)

    1016.10 (1)

  • Offer Price (Qty.)

    1017.40 (5)

NSE Live

Jul 29, 09:18
1017.60 0.95 (0.09%)
Volume
AVERAGE VOLUME
5-Day
449,562
10-Day
400,441
30-Day
597,022
4,368
  • Prev. Close

    1016.65

  • Open Price

    1015.00

  • Bid Price (Qty.)

    1016.50 (200)

  • Offer Price (Qty.)

    1018.00 (5)

Financials

2020 2019 2018 2017 2016
Nine Months Results of Natco Pharma (in Rs. Cr.) Dec '20 Dec '19 Dec '18 Dec '17 Dec '16  
Net Sales/Income from operations 1,342.00 1,370.10 1,570.00 1,362.30 1,343.70  
Other Operating Income -- -- -- -- 103.76  
Total Income From Operations 1,342.00 1,370.10 1,570.00 1,362.30 1,447.46  
EXPENDITURE  
Consumption of Raw Materials 283.60 221.20 254.00 283.00 419.76  
Purchase of Traded Goods 172.10 63.80 30.60 20.60 67.99  
Increase/Decrease in Stocks -10.50 -1.70 -6.30 -33.90 -27.29  
Power & Fuel -- -- -- -- --  
Employees Cost 290.60 279.30 263.30 206.20 153.95  
Depreciation 85.40 68.30 58.80 47.70 40.36  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 265.00 348.10 362.10 334.30 382.34  
P/L Before Other Inc. , Int., Excpt. Items & Tax 255.80 391.10 607.50 504.40 410.35  
Other Income 72.00 85.20 99.10 18.80 13.96  
P/L Before Int., Excpt. Items & Tax 327.80 476.30 706.60 523.20 424.31  
Interest 9.00 17.10 13.60 12.00 11.58  
P/L Before Exceptional Items & Tax 318.80 459.20 693.00 511.20 412.73  
Exceptional Items -- -- -- -- --  
P/L Before Tax 318.80 459.20 693.00 511.20 412.73  
Tax 66.50 85.70 149.30 109.10 95.24  
P/L After Tax from Ordinary Activities 252.30 373.50 543.70 402.10 317.49  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 252.30 373.50 543.70 402.10 317.49  
Equity Share Capital 36.40 36.40 36.80 36.90 34.86  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 13.85 20.53 29.47 22.94 18.14  
Diluted EPS 13.82 20.53 29.38 22.89 18.12  
EPS After Extra Ordinary  
Basic EPS. 13.85 20.53 29.47 22.94 18.14  
Diluted EPS. 13.82 20.53 29.38 22.89 18.12  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited